AI
BSX icon

Axiom Investors’s Boston Scientific BSX Stock Holding History

Axiom Investors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,641,563
Closed -$157M – 123
2025
Q4 		$157M Sell
1,641,563
-933,102
-36% -$91.5M 1.37% 17
2025
Q3 		$251M Sell
2,574,665
-743,949
-22% -$77M 1.85% 16
2025
Q2 		$356M Sell
3,318,614
-1,440,644
-30% -$146M 2.92% 9
2025
Q1 		$480M Buy
4,759,258
+1,006,828
+27% +$101M 4.61% 4
2024
Q4 		$335M Buy
3,752,430
+2,535,007
+208% +$223M 2.47% 11
2024
Q3 		$102M Buy
+1,217,423
New +$96M 0.9% 26

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Axiom Investors's BSX Position: Q1 2026 in Review

Axiom Investors sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 1,641,563 shares — an estimated $157M sold.

Axiom Investors first reported a position in BSX in Q3 2024 and held it in 6 quarters. The position peaked at $480M in Q1 2025. 1,679 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Axiom Investors reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
  • Axiom Investors sold 1,641,563 Boston Scientific shares in Q1 2026, an estimated $157M.
  • Axiom Investors first reported a position in Boston Scientific in Q3 2024 and held it in 6 quarters.
  • Axiom Investors's Boston Scientific position peaked at $480M in Q1 2025.
  • 1,679 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Axiom Investors's 13F filing for Q1 2026, filed 14 May 2026.